Corvus Pharmaceuticals, Inc.
CRVS · NASDAQ
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q2 | August 6, 2026 | — | — | — | -0.17 | — |
| 2026 Q1 | May 7, 2026 | — | — | -0.15 | -0.14 | — |
| 2025 Q4 | March 12, 2026 | — | 775.00K | -0.15 | -0.14 | -4.31% |
| 2025 Q3 | November 4, 2025 | — | — | -0.12 | -0.14 | -1.44% |
| 2025 Q2 | August 7, 2025 | — | — | -0.10 | -0.13 | +4.36% |
| 2025 Q1 | May 8, 2025 | — | — | -0.13 | -0.13 | -4.07% |
| 2024 Q4 | March 25, 2025 | — | — | -0.18 | -0.12 | -14.76% |
| 2024 Q3 | November 12, 2024 | — | — | -0.11 | -0.11 | +2.07% |
| 2024 Q2 | August 6, 2024 | — | — | -0.07 | -0.12 | +9.67% |
| 2024 Q1 | May 6, 2024 | — | — | -0.12 | -0.12 | -12.04% |
| 2023 Q4 | March 19, 2024 | 246.00K | — | -0.14 | -0.14 | — |
| 2023 Q3 | November 7, 2023 | — | — | -0.12 | -0.16 | +1.27% |
| 2023 Q2 | August 8, 2023 | — | — | -0.14 | -0.14 | +7.94% |
| 2023 Q1 | May 8, 2023 | — | — | -0.17 | -0.16 | -0.38% |
| 2022 Q4 | March 28, 2023 | — | — | -0.21 | 0.23 | +11.34% |
| 2022 Q3 | November 3, 2022 | — | — | -0.32 | -0.16 | -3.36% |